Fundraising Fox

Martin Tolar, MD, PhD

Founder

Founder at Alzheon

Cambridge, Massachusetts, United States

FoundedAlzheon

About

Martin Tolar, MD, PhD, is the Founder, President & CEO of Alzheon, Inc., which he established in 2013, and the Founder and Director of Tolion Health AI. He has previously held executive roles at Knome, NormOxys, CoMentis, and Pfizer, and in 2021 founded the International Neurodegenerative Disorders Research Center (INDRC), serving as chairman of its executive board through 2024. Tolar received his M.D. from Charles University in Prague and a Ph.D. in Neuroscience, trained in Neurology at Boston Medical Center, and served as an Assistant Professor of Neurology at Yale University School of Medicine.

Founder at Alzheon

Intro paths

→

In turn, Martin can intro founders to Alzheon's investors below.

Alzheon's investors · 1

ARCH Venture PartnersChicago · $50K – $250M checks · since 2014

Co-founders at Alzheon

MT
Martin Tolar, M.D., Ph.D.President and Chief Executive Officer
MTMartin Tolar
Martin TolarExecutive Officer, Director

Experience

  1. Tolion Health AIFounder & Directorcurrent2023 — presentBoston, Massachusetts, United States
  2. Alzheon, Inc.Founder, President & CEOcurrent2013 — presentGreater Boston Area
  3. Alzheimer's Drug Discovery FoundationBusiness Advisory Board & Scientific Review Boardcurrent2013 — presentGreater New York City Area
  4. The Alzheimer FoundationScientific Boardcurrent2011 — presentPrague, Czech Republic
  5. Advance Healthcare Management InstituteAcademic Boardcurrent2009 — presentPrague, Czech Republic
  6. INDRC - International Neurodegenerative Disorders Research CenterFounder, Chairman of Executive Board2021 — 2024Prague, Czech Republic
  7. Bellus HealthBoard of Directors2010 — 2017Montreal, Canada
  8. Knome, Inc.President & CEO2011 — 2013Cambridge, Massachusetts
  9. Suven Life Sciences Ltd.Board of Directors2007 — 2013Hyderabad, India
  10. NormOxys Inc.President & CEO2009 — 2011Wellesley, Massachusetts
  11. CoMentis, Inc.Executive Vice President & Chief Business Officer2008 — 2009South San Francisco, California
  12. CoMentis, Inc.Chief Scientific Officer2007 — 2008South San Francisco, California
  13. PfizerWorldwide Business Development2005 — 2007
  14. PfizerNeuroscience Clinical Development2001 — 2005
  15. Yale University School of MedicineAssistant Professor2002 — 2007

Skills & more

Drug Discovery99Lifesciences90Drug Development99Neuroscience50Clinical Development99Biotechnology99Commercialization42FDA32Technology Transfer21Genetics15Strategic Leadership5Oncology27
+11 moreClinical TrialsBiopharmaceuticalsNeurologyProgram ManagementMedical DevicesAnalyticsScienceClinical ResearchCTMSStrategyPharmaceutical Industry

From Martin's professional profile.

Frequently asked questions

Who is Martin Tolar, MD, PhD?
Martin Tolar, MD, PhD, is the Founder, President & CEO of Alzheon, Inc., which he established in 2013, and the Founder and Director of Tolion Health AI. He has previously held executive roles at Knome, NormOxys, CoMentis, and Pfizer, and in 2021 founded the International Neurodegenerative Disorders Research Center (INDRC), serving as chairman of its executive board through 2024. Tolar received his M.D. from Charles University in Prague and a Ph.D. in Neuroscience, trained in Neurology at Boston Medical Center, and served as an Assistant Professor of Neurology at Yale University School of Medicine.
Where does Martin Tolar, MD, PhD work?
Martin Tolar, MD, PhD is Founder of Alzheon.
What companies did Martin Tolar, MD, PhD found?
Martin Tolar, MD, PhD founded Alzheon.
Where did Martin Tolar, MD, PhD go to school?
Martin Tolar, MD, PhD studied at University of Michigan - Stephen M. Ross School of Business (Executive Management); Boston Medical Center (Residency in Neurology); University of Cincinnati College of Medicine (Ph.D., Neuroscience).

Same school

Also attended University of Michigan - Stephen M. Ross School of Business280

Alexandra FarmerPrincipal at Intel Capital, North AmericaTige SavageCo-founder at RevolutionWendy XiaoPartner at NorthzoneRob LawrenceSenior Finance Associate at GreycroftHyun KooPartner at March Capital PartnersRichard GuVice President at March Capital Partners

+ 274 more

Also attended University of Cincinnati College of Medicine1

Gopinath SundaramurthyInvestor at Ensemble VC

Also attended Charles University62

Taylor McPartland<UNKNOWN> at Pave Health VenturesKarel TušekManaging Partner at Tachles VCDimitri UhlikManaging Director at CaliberSteven PeraltaVP, Investments at Acumen AmericaMax PalkoPrincipal at Rockaway VenturesKateřina HavrlantOperating Partner at Rockaway Ventures

+ 56 more

Also attended Czech Technical University in Prague20

Flore BelmansAnalyst at Heran PartnersPedro Castel-BrancoPrincipal at Armilar Venture PartnersJorge MartínezPartner at Axon Partners GroupRadek BulaVenture Technologist at MitonCLukas HurychPartner at Credo VenturesMichal TaborskyPartner at Reflex Capital

+ 14 more

Shared employers

Also worked at Knome, Inc.3

Jorge CondeGeneral Partner at Andreessen HorowitzJulie YooGeneral Partner at Andreessen HorowitzPaul EneverPartner at Evidity Health Capital

Also worked at Pfizer152

Jigar RaythathaInvestor at Third Rock VenturesAbbie CelnikerInvestor at Third Rock VenturesErin MooreInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesRichard ChesworthInvestor at Third Rock VenturesBriggs MorrisonEntrepreneur Partner at MPM BioImpact

+ 146 more

Also worked at Yale University School of Medicine38

Karthik ArdhanareeswaranInvestor at GV (Google Ventures)Brittany de KouchkovskyDirector, University Relations at Osage University PartnersDavid Rosenthal, MDVenture Partner at AlleyCorpSophie RobinsonSenior Associate at Cure VenturesJonathan GertlerManaging Director at Bioventures InvestorsDouglas ReedGeneral Partner at Hatteras Venture Partners

+ 32 more